Hydroxychloroquine lung pharmacokinetics in critically ill patients with COVID-19

Different dosage regimens of hydroxychloroquine (HCQ) have been used to manage COVID-19 (coronavirus disease 2019) patients, with no information on lung exposure in this population. The aim of our study was to evaluate HCQ concentrations in the lung epithelial lining fluid (ELF) in patients infected...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Antimicrob Agents
Main Authors: Ruiz, S., Concordet, D., Lanot, T., Georges, B., Goudy, P., Baklouti, S., Mané, C., Losha, E., Vinour, H., Rousset, D., Lavit, M., Minville, V., Conil, J-M, Gandia, P.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7698654/
https://ncbi.nlm.nih.gov/pubmed/33259916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijantimicag.2020.106247
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados